The Scientist

» metabolism and disease/medicine

Most Recent

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Week in Review

Week in Review

By | March 15, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Novel Virus Entry Portal Found

Novel Virus Entry Portal Found

By | March 13, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

1 Comment

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

2 Comments

image: All In Proportion

All In Proportion

By | March 2, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Networking Medicine

Networking Medicine

By | March 2, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Do-It-Yourself Medicine

Do-It-Yourself Medicine

By | March 1, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

9 Comments

image: Instant Messaging

Instant Messaging

By | March 1, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

2 Comments

image: Stem Cell Trial Nearly Approved

Stem Cell Trial Nearly Approved

By | February 15, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Stem Cells: Safe Haven For TB

Stem Cells: Safe Haven For TB

By | February 5, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech